180 related articles for article (PubMed ID: 21197298)
1. Duloxetine for the management of fibromyalgia syndrome.
Scholz BA; Hammonds CL; Boomershine CS
J Pain Res; 2009 Jul; 2():99-108. PubMed ID: 21197298
[TBL] [Abstract][Full Text] [Related]
2. Milnacipran for the management of fibromyalgia syndrome.
Ormseth MJ; Eyler AE; Hammonds CL; Boomershine CS
J Pain Res; 2010 Mar; 3():15-24. PubMed ID: 21197306
[TBL] [Abstract][Full Text] [Related]
3. Duloxetine: a review of its safety and efficacy in the management of fibromyalgia syndrome.
Smith HS; Bracken D; Smith JM
J Cent Nerv Syst Dis; 2010; 2():57-72. PubMed ID: 23861632
[TBL] [Abstract][Full Text] [Related]
4. New treatment options for fibromyalgia: critical appraisal of duloxetine.
Uçeyler N; Offenbächer M; Petzke F; Häuser W; Sommer C
Neuropsychiatr Dis Treat; 2008 Jun; 4(3):525-9. PubMed ID: 18830399
[TBL] [Abstract][Full Text] [Related]
5. Duloxetine in the management of diabetic peripheral neuropathic pain.
Ormseth MJ; Scholz BA; Boomershine CS
Patient Prefer Adherence; 2011; 5():343-56. PubMed ID: 21845034
[TBL] [Abstract][Full Text] [Related]
6. A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine.
Rodrigues-Amorim D; Olivares JM; Spuch C; Rivera-Baltanás T
Front Psychiatry; 2020; 11():554899. PubMed ID: 33192668
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
8. Serotonin and Norepinephrine Reuptake Inhibitors.
Shelton RC
Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
[TBL] [Abstract][Full Text] [Related]
9. Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study.
Hunter AM; Leuchter AF; Cook IA; Abrams M; Siegman BE; Furst DE; Chappell AS
Pain Med; 2009; 10(4):730-8. PubMed ID: 19453962
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
Upadhyaya HP; Arnold LM; Alaka K; Qiao M; Williams D; Mehta R
Pediatr Rheumatol Online J; 2019 May; 17(1):27. PubMed ID: 31138224
[TBL] [Abstract][Full Text] [Related]
11. Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressant.
Keks NA; Hope J; Keogh S; Copolov DL
Australas Psychiatry; 2018 Oct; 26(5):537-540. PubMed ID: 30198305
[TBL] [Abstract][Full Text] [Related]
12. [Duloxetine for chronic pain management: pharmacology and clinical use].
Masuda R; Itoh M; Suzuki T
Masui; 2013 Jul; 62(7):814-21. PubMed ID: 23905404
[TBL] [Abstract][Full Text] [Related]
13. Focus on pain mechanisms and pharmacotherapy in the treatment of fibromyalgia syndrome.
Malemud CJ
Clin Exp Rheumatol; 2009; 27(5 Suppl 56):S86-91. PubMed ID: 20074446
[TBL] [Abstract][Full Text] [Related]
14. Duloxetine: a review of its use in the treatment of generalized anxiety disorder.
Carter NJ; McCormack PL
CNS Drugs; 2009; 23(6):523-41. PubMed ID: 19480470
[TBL] [Abstract][Full Text] [Related]
15. Clinical aspects and management of fibromyalgia syndrome.
Chong YY; Ng BY
Ann Acad Med Singap; 2009 Nov; 38(11):967-73. PubMed ID: 19956819
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment of fibromyalgia syndrome: new developments.
Staud R
Drugs; 2010; 70(1):1-14. PubMed ID: 20030422
[TBL] [Abstract][Full Text] [Related]
17. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.
Pergolizzi JV; Raffa RB; Taylor R; Rodriguez G; Nalamachu S; Langley P
Pain Pract; 2013 Mar; 13(3):239-52. PubMed ID: 22716295
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder.
Arnold LM; Rosen A; Pritchett YL; D'Souza DN; Goldstein DJ; Iyengar S; Wernicke JF
Pain; 2005 Dec; 119(1-3):5-15. PubMed ID: 16298061
[TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data.
Leombruni P; Miniotti M; Colonna F; Sica C; Castelli L; Bruzzone M; Parisi S; Fusaro E; Sarzi-Puttini P; Atzeni F; Torta RG
Clin Exp Rheumatol; 2015; 33(1 Suppl 88):S82-5. PubMed ID: 25786048
[TBL] [Abstract][Full Text] [Related]
20. Newer treatments for fibromyalgia syndrome.
Harris RE; Clauw DJ
Ther Clin Risk Manag; 2008 Dec; 4(6):1331-42. PubMed ID: 19337439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
